On May 11, President Obama stated at a news conference, “I will not rest until the dream of healthcare reform is achieved in the United States of America.” A Wall Street Journal article opined that “the Obama administration . . . is convinced it is smart enough to engineer more efficient medical practices out of… Continue reading With Mandated Healthcare, Your Healthcare Freedom of Choice is at Risk
Author: ANHUSA
FDA Seeks Your Suggestions for Increased Transparency
The FDA has established a Transparency Task Force, and has called for public comment. We certainly applaud this as a hopeful sign. Openness in government is imperative, and prompt disclosure to the public of government activity ensures legitimacy and accountability.
Congressional Panel Wants New Review of BPA Safety
As we have reported earlier in Pulse of Health Freedom, chemicals in the packaging, surfaces or contents of many products may cause long-term health effects, including cancers of the breast, brain and testicles; lowered sperm counts, early puberty and other reproductive system defects; diabetes; attention deficit disorder, asthma and autism. A decade ago, the government… Continue reading Congressional Panel Wants New Review of BPA Safety
Big Pharma and the FDA: Suppress the Science, Ban the Natural Substances, Sell the Drugs!
In 2005, an up-and-coming pharmaceutical company made a big mistake: they invested millions of dollars into developing a drug only to discover that the only active ingredient of the drug, pyridoxamine, was really a common, naturally occurring substance that has been sold for decades at low cost to consumers in the form of a dietary… Continue reading Big Pharma and the FDA: Suppress the Science, Ban the Natural Substances, Sell the Drugs!
In Memoriam: Dr. Abram Hoffer, Vitamin Pioneer
Dr. Abram Hoffer died this week at the age of 91. A renowned Canadian psychiatrist, Dr. Hoffer was instrumental in discovering the importance of megadoses of vitamins in the treatment of psychiatric disorders like schizophrenia and bipolar disorder, and was a pioneer in the field of orthomolecular medicine.
Creating a Generation of Drugged Children
Last November, the journal Pediatrics published research that found medication use among children across the United States is dramatically increasing as more kids are being treated for diabetes, hypertension, obesity, asthma, and attention-deficit hyperactivity disorder (ADHD). Using a database of prescription claims from children with private health insurance, they were able to find prescriptions for… Continue reading Creating a Generation of Drugged Children
Will FDA Call Tomatoes a “New Drug”?
Scientists say the naturally occurring antioxidant lycopene, found in abundance in tomatoes, helps block the body from absorbing “bad” LDL cholesterol. This bad cholesterol is primarily responsible for clogging arteries.
Vermont Acts to Make Drug Makers’ Gifts Public
Under a new Vermont law, drug and device manufacturers will have to publicly disclose all gifts (in direct payments, speaking and consulting fees, grants, food, lodging and transportation, and books) they make to healthcare providers. The law will require specific disclosure of doctors’ names, dollar amounts, and the medical products to which the spending is… Continue reading Vermont Acts to Make Drug Makers’ Gifts Public
Nineteen Members of Congress Ask FDA for Official Warning About Mercury in Dental Filling Amalgams
A bipartisan letter authored by Rep. Diane Watson (D-CA) and Rep. Dan Burton (R-IN), and co-signed by congresswomen and men from twelve states, has been sent to the FDA urging them to require clear warnings about mercury toxicity to every dental patient, and to establish specific protections for children and young women.
FDA to Receive More Money from Drug Manufacturers, But Denies “Undue Influence”
The proposed budget of the US Food and Drug Administration (FDA) is worrying the Democrats. They are concerned that FDA’s annual increases in industry user fees—$828 million from manufacturers of medical and food products, including hundreds of millions drug manufacturers pay annually to help speed the review of new medicines—might compromise the agency’s independence.